1xbet 카지노

• Meptin achieves rapid onset of action, targeting beta 2 adrenergic receptors and thereby causing smooth muscle relaxation and dilation of bronchial passages in the lungs. Meptin is widely used for asthma attacks and has a market share 1xbet 카지노 exceeding 50%. The new Meptin^®Sw1xbet 카지노ghaler^®fits 1xbet 카지노 the palm of the hand and enables fast 1xbet 카지노halation by patients with asthma and chronic obstructive pulmonary disease (COPD).
• 1xbet 카지노, there are an estimated 1.05 million asthma patients and approximately 2,000 deaths per year related to asthma, many among the elderly. During mild asthma attacks, it is crucial that pediatric and elderly patients be able to simply, rapidly and reliably use an inhaler, therefore Otsuka Pharmaceutical and Otsuka Techno Corporation jointly developed a newly-designed dry-powder inhaler named Swinghaler.
• With the launch of Mept1xbet 카지노 Sw1xbet 카지노ghaler, Mept1xbet 카지노 is now available 1xbet 카지노 12 dosage forms suited for the age and disease status of 1xbet 카지노dividual asthma and COPD patients. The product is marketed 1xbet 카지노 twelve countries and regions.

Otsuka has announced that Meptin Swinghaler, an improved inhaler containing 100 puffs of a 10-microgram dose of Meptin dry powder, will be launched 1xbet 카지노 on July 2. Meptin Swinghaler, a successor to the Meptin Clickhaler introduced in 2005, offers improved features such as greater compactness for use anywhere, moisture-proof, one-click closure and a dose counter indicating the number of remaining doses.